Leveraging Natural Killer Cell Innate Immunity against Hematologic Malignancies: From Stem Cell Transplant to Adoptive Transfer and Beyond

Numerous recent advancements in T-cell based immunotherapies have revolutionized the treatment of hematologic malignancies. In the race towards the first approved allogeneic cellular therapy product, there is growing interest in utilizing natural killer (NK) cells as a platform for off-the-shelf cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chenyu, Horwitz, Mitchell E., Rein, Lindsay A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820370/
https://www.ncbi.nlm.nih.gov/pubmed/36613644
http://dx.doi.org/10.3390/ijms24010204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820370/
https://www.ncbi.nlm.nih.gov/pubmed/36613644
http://dx.doi.org/10.3390/ijms24010204

Ejemplares similares